NCT04483830View on ClinicalTrials.gov

Suloexide in the Treatment of Early Stages of COVID-19

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

243

Participants

Timeline

Start Date

June 5, 2020

Primary Completion Date

August 6, 2020

Study Completion Date

September 7, 2020

Conditions

Covid19

Interventions

DRUG

Sulodexide

an oral dose of 2 capsules each day for 21 days

DRUG

Placebo

an oral dose of 2 capsules each day for 21 days

Trial Locations (1)

83449

Clinedem, San Luis Río Colorado

Sponsors

Collaborators (1)

Alfasigma S.p.A.

All Listed Sponsors

collaborator

Alfasigma S.p.A.

INDUSTRY

lead

Clinedem

OTHER